| Crystal Structure of hPNMT in Complex AdoHcy and 2-Aminobenzimidazole | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×AX7; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 2-amino-1H-benzo[d]imidazol-7-ol | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES0; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and Formanilide | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×FAN; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 5-fluoro-1H-benzo[d]imidazol-2-amine | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ET2; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 5-chloro-1H-benzo[d]imidazol-2-amine | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×VGD; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 2-Amino-1-methylbenzimidazole | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES7; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 4-Bromo-1H-imidazole | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES3; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 6-Chloropurine | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES4; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 6-Aminoquinoline | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES5; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 4-quinolinol | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES1; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and Adenine | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ADE; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 1-Aminoisoquinoline | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×1SQ; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 6-Chlorooxindole | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES2; |
|
| Crystal structure of human PNMT in complex adohcy, resorcinol and imidazole | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×RCO; 2×IMD; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 5-Chlorobenzimidazole | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES9; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and Bound Phosphate | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×PO4; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 2-Hydroxynicotinic acid | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×ES6; |
|
| Crystal Structure of hPNMT in Complex AdoHcy and 2-amino-1H-benzo[d]imidazol-6-ol | | homo-2-mer | 14-281 | 100 | 2×SAH; 2×172; |
|
| Structure of human pnmt complexed with cofactor product adohcy and inhibitor SK&F 64139 | | homo-2-mer | 14-280 | 100 | 2×SKA; 2×SAH; |
|
| Crystal structure of human phenylethanolamine N-methyltransferase (PNMT) in complex with (2S)-2-ami… | | homo-2-mer | 15-280 | 100 | 1×SAH; 1×CD; 15×EDO; 1×KNX; |
|
| Crystal structure of human phenylethanolamine N-methyltransferase (PNMT) in complex with (2S)-2-ami… | | homo-2-mer | 15-280 | 100 | 3×EDO; 2×KNX; |
|
| Crystal structure of human phenylethanolamine N-methyltransferase (PNMT) in complex with (2S)-2-ami… | | homo-2-mer | 15-280 | 100 | 1×SAH; 3×EDO; 1×CD; 1×K; 1×U87; |
|
| Crystal Structure of hPNMT in Complex with bisubstrate inhibitor (2R,3R,4S,5S)-2-(6-amino-9H-purin-… | | homo-2-mer | 16-280 | 100 | 2×JIL; 2×TRS; |
|
| Crystal Structure of hPNMT in Complex with bisubstrate inhibitor N-(3-((((2S,3S,4R,5R)-5-(6-amino-9… | | homo-2-mer | 17-280 | 100 | 2×2D5; 2×TRS; |
|
| Structure of hPNMT with inhibitor 3-fluoromethyl-7-thiomorpholinosulfonamide-THIQ and AdoMet | | monomer | 17-280 | 100 | 1×SAM; 1×F21; |
|
| Structure of hPNMT with inhibitor 3-fluoromethyl-7-trifluoropropyl-THIQ and AdoHcy | | monomer | 21-281 | 100 | 1×SAH; 1×FTS; |
|
| CRYSTAL STRUCTURE OF HUMAN PNMT COMPLEXED WITH SK&F 29661 AND ADOHCY(SAH) | | monomer | 22-282 | 100 | 1×SAH; 1×SKF; |
|
| Structure of human PNMT in complex with inhibitor 3-hydroxymethyl-7-nitro-THIQ and AdoMet (SAM) | | monomer | 20-280 | 100 | 1×SAM; 2×HNT; |
|
| The structure of Phenylethanolamine N-methyltransferase in complex with S-adenosylhomocysteine and … | | monomer | 22-282 | 100 | 1×SAH; 1×IDI; |
|
| The structure of Phenylethanolamine N-methyltransferase in complex with S-adenosylhomocysteine and … | | monomer | 22-282 | 100 | 1×SAH; 1×LY1; |
|
| Crystal Structure of hPNMT in Complex With anti-9-amino-5-(trifluromethyl) benzonorbornene and AdoH… | | monomer | 23-281 | 100 | 1×LT3; 1×SAH; |
|
| Structure of hPNMT with inhibitor 3-Hydroxymethyl-7-(N-4-chlorophenylaminosulfonyl)-THIQ and AdoHcy | | monomer | 23-280 | 100 | 1×F83; 1×SAH; |
|
| Structure of PNMT with S-adenosyl-L-homocysteine and the semi-rigid analogue acceptor substrate cis… | | monomer | 23-280 | 100 | 1×SAH; 1×CTL; |
|
| Structure of PNMT complexed with S-adenosyl-L-homocysteine and the acceptor substrate octopamine | | monomer | 24-281 | 100 | 1×PO4; 1×SAH; 1×OTR; |
|
| Crystal Structure of E185Q hPNMT in Complex With Octopamine and AdoHcy | | monomer | 24-281 | 99.61 | 1×SAH; 1×OTR; 1×EDO; |
|
| Structure of human PNMT complexed with S-adenosyl-homocysteine and an inhibitor, trans-(1S,2S)-2-am… | | monomer | 23-280 | 100 | 1×SAH; 1×TTL; |
|
| Structure of K57A hPNMT with inhibitor 3-Hydroxymethyl-7-(N-4-chlorophenylaminosulfonyl)-THIQ and A… | | monomer | 24-280 | 99.61 | 1×F83; 1×SAH; |
|
| Crystal Structure of hPNMT in Complex With Noradrenaline and AdoHcy | | monomer | 24-280 | 100 | 1×SAH; 1×LNR; |
|
| Crystal Structure of hPNMT in Complex With Noradrenochrome and AdoHcy | | monomer | 24-280 | 100 | 1×SAH; 1×LT2; |
|
| Structure of hPNMT with inhibitor 7-(N-4-chlorophenylaminosulfonyl)-THIQ and AdoHcy | | monomer | 24-280 | 100 | 1×SAH; 1×TMJ; |
|
| Crystal Structure of hPNMT in Complex With 3-trifluoromethyl phenylethanolamine and AdoHcy | | monomer | 24-280 | 100 | 1×LT5; 1×SAH; 1×EDO; |
|
| Structure of K57A hPNMT with inhibitor 7-(N-4-chlorophenylaminosulfonyl)-THIQ and AdoHcy | | monomer | 24-280 | 99.61 | 1×SAH; 1×TMJ; |
|
| Structure of K57A hPNMT with inhibitor 3-fluoromethyl-7-thiomorpholinosulfonamide-THIQ and AdoHcy | | monomer | 24-280 | 99.61 | 1×F21; 1×SAH; |
|
| Crystal Structure of E185D hPNMT in Complex With Octopamine and AdoHcy | | monomer | 24-280 | 99.61 | 1×SAH; 1×OTR; |
|